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There is a well-known association between low socioeco-nomic status (SES) and high incidence of and mortality 
from coronary heart disease.1,2 One possible explanation is the 
inverse relationship between SES and the prevalence of almost 
all well-established cardiovascular risk factors.3 Furthermore, 
existing literature suggests that SES-related differences may 
exist in quality of care, with low-SES patients receiving fewer 
relevant diagnostic examinations and less care than patients 
with high SES (eg, coronary arteriography, coronary interven-
tion, and evidence-based medical treatment).2,4–6
Primary percutaneous coronary intervention (PPCI) is the 
recommended treatment for ST-elevation myocardial infarc-
tion (STEMI). The efficacy of PPCI has been documented in 
several randomized controlled trials comparing PPCI with 
thrombolysis.7,8 There also appear to be SES-related differ-
ences in care among STEMI patients; several studies have 
observed that low-SES patients eligible for PPCI are less 
likely to receive the treatment than their high-SES counter-
parts.2,4,5 However, the exact role of SES in relation to post-
STEMI outcomes remains poorly understood. Most studies 
on this topic neither provide detailed individual-level data 
about SES nor explore different dimensions of SES.2,4,6,9 They 
also include only limited details about patient and treatment 
characteristics,2,9 making it difficult to clarify the mechanisms 
driving the possibly SES-related differences in clinical out-
comes. Furthermore, no studies include follow-up informa-
tion about medical treatment beyond 90 days after hospital 
discharge, although differences in long-term adherence to 
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642  Circ Cardiovasc Interv  October 2012
secondary medical prophylaxis may potentially be an impor-
tant factor underlying SES-related differences in clinical 
outcomes.1,5,6,10
We, therefore, conducted a follow-up study of PPCI-treated 
patients from Denmark, a country that provides tax-financed 
health care to all residents and considers PPCI as the stan-
dard treatment for STEMI, which should theoretically guaran-
tee equal access to treatment independent of individual SES. 
We compared patient and treatment characteristics, as well as 
short- and long-term outcomes after PPCI according to SES in 
unselected real-world patients.
Methods
We completed a population-based, historical follow-up study in the 
Western part of Denmark with ≈3.3 million inhabitants (56% of the 
Danish population). The Danish National Health Service provides 
tax-financed health care, guaranteeing unfettered access to medical 
care. All acute medical conditions are treated exclusively at public 
hospitals. The Danish Civil Registration System keeps records of sex, 
date of birth, and changes in vital status. The records carry each pa-
tient’s unique civil registration number, which is used for all Danish 
registries, thereby enabling unambiguous record linkage among 
registries.
Identification of Patients
PPCI has been implemented as the standard treatment for STEMI in 
Denmark since the DANAMI-2 (Danish Trial in Acute Myocardial 
Infarction-2) trial,8 and Danish STEMI patients are almost exclusive-
ly treated with PPCI. The Western Denmark Heart Registry collects 
detailed data related to patients and procedures for all interventions 
conducted in the 3 coronary intervention centers in West Denmark: 
Odense University Hospital, Aarhus University Hospital (Skejby), 
and Aarhus University Hospital (Aalborg). Reporting to the registry 
is mandatory, and data quality is ensured by automatic validation 
rules at data entry, combined with systematic validation procedures 
and random spot-checks of data after entry.11 We identified all Danish 
STEMI patients from 2002 to 2008 who underwent PPCI within 12 
hours of symptom onset (n=7385).
Socioeconomic Status
The Integrated Database for Labor Market Research collects 
 individual-level socioeconomic data on Danish citizens. From the 
Integrated Database for Labor Market Research, we  obtained infor-
mation about employment status the year before  hospital admission 
for each patient (employed, unemployed, or pensioner). Pensioner in-
dicates that the patient received a pension, an early retirement benefit, 
or was otherwise economically inactive.
We also retrieved personal income information for each patient 
and cohabiting partner, including imputed rent for owner-occupied 
dwellings, interests received, pension withdrawals, unemployment 
benefits, and other social security benefits. This broad definition of 
income was used in an attempt to reflect the wealth of each patient 
because it has been suggested that wealth is a more sensitive indicator 
of SES than income.12 We calculated the combined average income 
of each patient and their cohabiting partner in the 5 years before ad-
mission. All patients were divided into tertiles of increasing income.
Information regarding the highest completed level of education as 
registered the year before admission was obtained from the Student 
Registry of Statistics Denmark. Patients were divided into 3 groups: 
long (short-, medium-, and long-term higher education), medium 
(vocational education, upper or lower secondary school), and short 
(primary school).
Patient and Treatment Characteristics
We obtained data about hypertension, smoking status, Killip class 
on admission, duration of symptoms, and all procedure-related data 
from the Western Denmark Heart Registry.
The Danish National Patient Registry collects data for all hospi-
talizations at Danish hospitals, including dates of admission and dis-
charge and discharge diagnoses coded according to the International 
Classification of Diseases (10th revised edition since 1993). Based on 
the past 10 years of each patient’s hospitalization history, we computed 
the Charlson Comorbidity Index score that has been validated for the 
prediction of mortality for patients with a wide range of conditions13 
and has been validated for use with hospital discharge registry data.14 
We defined 3 levels of comorbidity: a score of 0 (low), a score of 1 to 
2 (moderate comorbidity), and a score of >2 (high comorbidity).
The Danish Transfusion Database is a national registry monitoring 
the use of all blood components. We obtained information regarding 
the types and number of blood components administered to the pa-
tients from the day of admission to 7 days postadmission.
We obtained data regarding the use of cardiovascular drugs from 
the Danish Medicines Agency’s Register of Medicinal Product 
Statistics, a national prescription registry that contains information 
on all redeemed prescriptions for reimbursable drugs dispensed from 
all pharmacies in Denmark. The information includes type of drug 
(according to the Anatomic Therapeutic Chemical classification sys-
tem) and date dispensed. We identified all prescriptions for aspirin, 
clopidogrel, nitroglycerin, statins, angiotensin-converting enzyme 
inhibitors, angiotensin II receptor antagonists, and selective and 
nonselective β-blockers filled until 2 years after hospital discharge. 
All the drugs were available only by prescription, except for aspi-
rin. However, aspirin is available by prescription, and patients with 
chronic diseases and pensioners are reimbursed for it.
For a subset of patients (n=4856), data from the Laboratory 
Information Systems in the Central Denmark and North Denmark 
Regions were obtained, including data regarding hemoglobin, serum 
creatinine level, total cholesterol, troponin T, and the creatine kinase-
myocardial band. For all laboratory values, the highest value measured 
over 7 days, starting from the time of admission, was obtained except 
for hemoglobin where the lowest value was obtained. We calculated 
the estimated glomerular filtration rate using the 4-component modi-
fication of diet in renal disease equation incorporating age, race, sex, 
and serum creatinine level.15 Race was not included because race data 
were unavailable. Based on hemoglobin values, we classified anemia 
into categories for men and women as follows: no anemia (men, >8.4 
mmol/L; women, >7.4 mmol/L); borderline (men, 7.9–8.4 mmol/L; 
women, 6.9–7.4 mmol/L); mild (men, 6.6–7.8 mmol/L; women, 
5.6–6.8 mmol/L); moderate (men, 5.4–6.5 mmol/L; women, 4.4–5.5 
mmol/L); and  severe (men, ≤5.3 mmol/L; women, ≤4.3 mmol/L).
WHAT IS KNOWN
•	 There is a well-known association between low 
socioeconomic status (SES) and high incidence of 
and mortality from coronary heart disease.
•	 There also appear to be SES-related differences 
in care among ST-elevation myocardial infarction 
patients, but the exact role of SES in relation to post-
ST-elevation myocardial infarction outcomes remains 
poorly understood.
WHAT THE STUDY ADDS
•	 Even in a universal, tax-financed, healthcare system, 
low-SES ST-elevation myocardial infarction patients 
treated with primary percutaneous coronary interven-
tion face a worse prognosis than high-SES patients.
•	 The poor outcome seems to be primarily explained by 
differences in baseline patient characteristics, rather 
than differences in acute treatment or long-term sec-
ondary medical prophylaxis.
•	 Employment status and income, but not education 
level, were associated with clinical outcomes.
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Clinical Outcomes
The primary end point of this study was major adverse cardiac events 
(MACE, defined as cardiac death, recurrent myocardial infarction 
[MI], and target vessel revascularization) at maximum follow-up.
Data on recurrent MI were obtained from The National Patient 
Registry (information was available until the end of 2009). We de-
fined a recurrent MI as hospitalization for MI occurring >28 days 
after the index PCI.16
Deaths were ascertained from the Danish Civil Registration System 
(information was available until the end of 2010). Data on target ves-
sel revascularization were obtained from the Western Denmark Heart 
Registry. Target vessel revascularization was defined as a new PCI on 
the index vessel.
Cause of death was retrieved from the Cause of Death Registry. When 
a Danish citizen dies, the cause of death is reported using International 
Classification of Diseases (10th revised edition) diagnosis codes. The 
following codes defined cardiac death: I0, I1, I20–25, I27, I3, I4, I50, 
I51, R96, and R99 (information was available until the end of 2009).
Statistical Analyses
The patients were censored at the time of death or followed for up to 
8.8 years. Mean follow-up time was 3.7 years. We compared baseline 
characteristics using Student t test for continuous variables and the χ2 
test for categorical variables. We used Cox proportional-hazards re-
gression to compute crude and adjusted hazard ratios and 95% CIs for 
the end points in each stratum of income, education, and employment 
status, using high income, long education, and employed as reference. 
The proportional hazards assumption was checked for each variable 
by visual inspection and by using the scaled Schoenfeld residuals. For 
all measures of SES, the hazards were proportional throughout the 
follow-up period. All tests of significance were 2-tailed, with P<0.05 
considered statistically significant.
First, we adjusted the crude hazard ratios for patient characteris-
tics. To examine the interrelations between the 3 different indicators 
of SES, we mutually adjusted for socioeconomic factors (eg, models 
examining the effects of income on mortality were adjusted for educa-
tion and employment). Next, we added adjustments for the admission 
findings and procedure-related data. Finally, we added an adjustment 
for medical treatment during follow-up. All variables listed in online-
only Data Supplement Table I were included as covariates in the mul-
tivariable models. The analyses were repeated in strata of men and 
women to examine whether sex affected the associations. Because it 
might be difficult to use employment status, income, and education 
as a reflection of SES when the patients in question are above retire-
ment age, we repeated the analyses twice while first restricting it to 
patients <65 years of age and then additionally restricting to patients 
<60 years of age. The analyses were also repeated without mutual 
adjustment for socioeconomic factors.
The number of patients with complete data for all measured variables 
was 2408 (33%). For most variables, only 0.0% to 11% of patients had 
missing data. However, 23% to 40% of patients had missing data re-
garding laboratory data; smoking status; and history of hypertension, 
diabetes mellitus, and hypercholesterolemia. We used multiple impu-
tation to impute missing values for all variables. In addition to all mea-
sured variables, we included the event indicator and the Nelson-Aalen 
estimator of the cumulative hazard to survival time in the imputation 
model.17 Analyses were conducted on 5 imputed data sets, and the re-
sults were combined using Rubin’s rules.18 To examine the robustness 
of our analyses, we also conducted complete case analyses restricted 
to patients with available information about all variables.
We analyzed data using STATA version 11.0 (StataCorp, College 
Station, TX). Our study was approved by the Danish Data Protection 
Agency (journal number 2008-41-1835).
Results
Patient and Treatment Characteristics
Table 1 presents the patient characteristics, admission findings 
and data related to the PPCI procedure, and medical treatment 
during follow-up according to SES as indicated by income, 
education, and employment status. In general, female sex, older 
age, diabetes mellitus, hypertension, previous MI, impaired 
renal function, anemia, longer duration of symptoms, high Kil-
lip class on admission, use of blood transfusions, and high level 
of comorbidity were more prevalent among low-SES patients 
than high-SES patients. Low-SES patients were less likely to 
be treated with glycoprotein IIb/IIIa inhibitors during PPCI; 
they had a lower TIMI Grade flow after PPCI, more in-lab com-
plications, less successful procedures, and fewer stent implan-
tations. Of the stents implanted, fewer were drug-eluting stents 
compared with high-SES patients. Low-SES patients were 
less likely to be treated with statins than high-SES patients but 
more likely to be treated with diuretics, angiotensin-converting 
enzyme inhibitors, and nitroglycerin during follow-up. The 
low-SES patients were more likely to live alone.
Low-income patients and pensioners had lower total cho-
lesterol levels than their counterparts. The left main coronary 
artery was also more likely to be identified as the culprit lesion 
among low-income patients and pensioners, whereas fewer 
of these patients were active smokers compared with high-
income and employed patients, respectively. When education 
was used as the indicator of SES, these differences were not 
present; in contrast, the least educated patients were more 
likely to be active smokers than their counterparts (for the full 
table, see online-only Data Supplement Table I).
Clinical Outcomes
Overall, 1357 patients (18.4%) experienced a MACE during 
follow-up. Table 2 presents clinical end points after maximum 
follow-up according to income, education, and employment 
status. Compared with high-income patients, low- and medium-
income patients had a higher cumulative risk of MACE after 
maximum follow-up because of a higher incidence of cardiac 
death and recurrent MI (online-only Data Supplement Table 
II). After adjustment for patient characteristics, the differences 
in MACE were substantially attenuated and no longer statis-
tically significant. Further adjustment for admission findings, 
procedure-related data, and medical treatment during follow-
up had very modest effects on the associations.
With education as the indicator of SES, no statistically sig-
nificant differences were observed in the crude or adjusted 
hazard ratios of MACE between the groups.
Unemployed patients and pensioners had a higher cumu-
lative incidence of MACE after maximum follow-up, pri-
marily explained by higher cardiac mortality and a greater 
incidence of target vessel revascularization (online-only Data 
Supplement Table II). After adjustment for patient character-
istics, only the differences in MACE and cardiac mortality 
after maximum follow-up remained statistically significant. 
There were no significant changes after further adjustment for 
admission findings, procedure-related data, and medical treat-
ment during follow-up.
When comparing the cumulative incidence of MACE and 
cardiac death after 30 days and 1 year and all-cause mortality 
at 30 days, 1 year, and maximum follow-up, the results were 
similar (online-only Data Supplement Table II).
No substantial differences were observed when the analyses 
were stratified according to sex, the population was restricted 
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Table 1. Patient Characteristics, Admission Findings and Procedure-Related Data, and Medical Treatment During Follow-Up 
According to Socioeconomic Status
Variable
Income Education Employment Status
High 
(n=2508)
Medium 
(n=2439)
Low 
(n=2438)
Long 
(n=1013)
Medium 
(n=2582)
Short 
(n=3790)
Employed 
(n=2826)
Unemployed 
(n=436)
Pensioner 
(n=4123)
Patient characteristics
 Male sex, n% 82.1 72.3 64.9* 82.0 82.0 64.8* 84.4 73.6 65.4*
 Age, n%
  <65 y 82.1 54.8 20.6* 65.5 66.5 40.1* 93.3 94.3 20.7*
  65–80 y 14.8 36.0 55.1* 30.0 29.2 40.5* 6.4 5.5 57.9
  >80 y 3.1 9.2 24.3* 4.5 4.4 19.4* 0.3 0.2 21.5
 Comorbidity, n%
  Low 75.8 65.1 57.0* 75.2 68.6 61.9* 79.9 71.1 56.1*
  Medium 21.3 27.6 32.2* 21.5 25.2 29.7* 18.0 25.9 33.2*
  High 2.9 7.3 10.8* 3.3 6.3 8.4* 2.1 3.0 10.7*
 Diabetes mellitus, n% 7.5 9.5 11.6* 6.1 8.5 11.1* 6.4 9.7 11.6*
  Previous myocardial 
infarction, n%
13.3 16.6 17.5* 13.2 15.5 16.6* 12.0 17.6 18.2*
 Smoking status, n%
  Never 19.3 18.6 26.3* 25.4 17.3 22.9* 16.3 13.3 25.8*
  Previous 21.7 23.1 28.3* 27.0 24.6 23.3 18.2 14.2 29.7*
  Active 59.0 58.3 45.4* 47.6 58.1 53.8* 65.5 72.5 44.5*
Admission findings and procedure-related data
  Duration of  
symptoms, h
3.3 
(3.3–3.4)
3.4 
(3.3–3.5)
3.7 
(3.6–3.8)*
3.4 
(3.2–3.5)
3.3 
(3.2–3.4)
3.7 
(3.6–3.7)*
3.3 
(3.2–3.4)
3.3 
(3.1–3.5)
3.6 
(3.6–3.7)*
 Killip class on admission, n%
  I 93.1 91.5 87.0* 91.3 92.2 89.3* 93.8 91.9 88.2*
  II 3.3 4.5 6.9* 4.6 4.2 5.4 3.0 4.4 6.2*
  III 1.8 2.0 2.8* 1.9 1.7 2.6 1.6 2.1 2.6*
  IV 1.8 2.0 3.3* 2.2 1.9 2.7 1.6 1.6 3.0*
 Stent implantation, n% 94.4 93.2 91.1* 94.4 94.0 91.8* 95.4 94.1 91.0*
 Stent type, n%
  BMS 50.0 53.3 59.0* 48.6 50.3 58.0* 48.6 48.7 58.4*
  DES 50.0 46.7 41.0* 51.4 49.7 42.0* 51.4 51.3 41.6*
 TIMI Grade flow after PCI, n%
  0 1.7 1.9 3.4* 1.0 1.5 3.3* 1.6 0.9 3.0*
  1 0.7 1.4 1.4* 0.8 1.2 1.4 0.8 0.7 1.5*
  2 4.8 5.1 6.2 5.6 4.4 5.9* 4.2 4.3 6.3*
  3 92.7 91.5 88.9* 92.6 92.9 89.4* 93.4 94.1 89.2*
 In-lab complication, n% 2.3 3.1 3.5* 2.5 2.1 3.7* 2.2 3.2 3.4*
 Successful procedure, n% 97.0 96.5 93.8* 97.5 96.6 94.8* 97.6 97.7 94.4*
  Red blood cell 
transfusion, n%
1.6 2.8 4.3* 2.5 2.1 3.5* 1.7 1.2 3.8*
 Heparin during PCI, n% 98.2 98.2 98.6 98.0 98.3 98.4 98.2 97.7 98.4
 GPIIb/IIIa during PCI, n% 73.9 70.5 64.5* 74.2 71.3 67.3* 75.2 77.8 65.0*
 Aspirin during PCI, n% 96.9 96.9 95.7 95.9 96.7 96.6 96.7 96.8 96.3
 Clopidogrel during PCI, n% 84.4 82.8 83.2 84.5 84.4 82.6 84.3 81.5 83.2
Medical treatment during follow-up
 Aspirin, n%
  1 y 91.8 91.0 90.7 89.4 91.1 91.7 92.5 87.7 90.5
  2 y 89.4 88.8 89.0 87.3 88.7 89.8 89.6 84.4 89.2
(continued)
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to patients <60 or 65 years of age, or without mutually adjust-
ing for socioeconomic factors. Finally, no substantial differ-
ences were observed when the findings from the analyses 
based on the entire study population were compared with the 
complete case analyses (data not shown).
Discussion
The main findings of our study were that low-SES patients 
presenting with STEMI and treated with PPCI were older 
and had a worse baseline risk profile than high-SES patients. 
These differences could almost entirely explain the poorer 
crude short- and long-term outcomes in low-SES patients 
compared with high-SES patients. Differences in admission 
findings, procedure-related data, and the use of long-term sec-
ondary medical prevention only had minor effects.
Our study is in accordance with and extends the findings 
from many other studies, which have observed that SES-related 
differences in clinical outcome can be either partially1,2,6,19 
or completely10,20 ascribed to differences in baseline patient 
characteristics. However, the possibility of making direct 
comparisons with and between previously published studies 
is somewhat limited. SES is a multidimensional concept in 
which the different dimensions (eg, income, education, and 
employment status) are closely related. With few exceptions, 
previously published studies have focused on only a single 
measure of SES and have consequently been unable to explore 
the independent roles of the different dimensions of SES. 
Furthermore, very few studies have included data regarding 
individual-level SES measures.1,20,21 Various area-based mea-
sures of SES have been used—for example, median household 
income, the proportion of university-educated subjects, and 
employment rates, as well as composite indexes formed by 
combining these variables. However, use of area-based mea-
sures to estimate an individual’s SES results in considerable 
misclassification and individual-level measures are, therefore, 
preferred.22 The finding that employment status and income, 
rather than education level, were predictors of clinical out-
come in our study is also partly in accordance with the results 
of previous studies. Aside from different area-based SES 
indexes, income has so far been the most frequently used mea-
sure of SES. Most studies focusing on income have observed 
that differences in clinical outcome persist after adjustment 
for differences in patient characteristics,2,6,19 although this 
finding has not been confirmed by all studies.20 In addition, 
among studies using education level as the measure of SES, 
some studies observed differences in outcome that persisted 
after adjustment for patient characteristics,1 whereas others 
observed that differences could be explained by differences 
in baseline characteristics.23 One study that used both income 
and education level as measures of SES observed that income 
was associated with poor outcomes in all patients, whereas 
education level was only associated with outcome in patients 
<65 years of age.21 It is possible that healthy choices are incul-
cated early in the Danish school system experience, which 
might explain why we found no association between educa-
tional level and outcome. To our knowledge, no recent studies 
Table 1. Continued
Variable
Income Education Employment Status
High 
(n=2508)
Medium 
(n=2439)
Low 
(n=2438)
Long 
(n=1013)
Medium 
(n=2582)
Short 
(n=3790)
Employed 
(n=2826)
Unemployed 
(n=436)
Pensioner 
(n=4123)
 Clopidogrel, n%
  1 y 67.1 66.4 65.9 67.4 67.5 65.5 66.6 63.5 66.8
  2 y 8.7 10.3 9.8 10.5 10.1 8.9 8.1 12.6 10.3*
 β-blocker, n%
  1 y 82.1 82.2 79.9 79.5 83.5 80.5* 82.7 77.4 81.0*
  2 y 76.6 78.7 76.6 74.7 78.4 77.3* 77.4 71.5 78.0*
 Statin, n%
  1 y 91.9 87.2 85.1* 90.4 89.9 86.4* 91.1 86.1 86.2*
  2 y 89.6 85.7 83.8* 87.6 88.0 85.2* 88.8 82.5 85.3*
 ACE inhibitor, n%
  1 y 54.6 55.7 58.1* 53.8 56.9 56.0 54.5 53.9 57.5*
  2 y 52.7 54.0 57.9* 54.4 54.7 54.8 52.1 51.2 57.2*
 Diuretics, n%
  1 y 22.3 34.4 43.9* 25.5 27.2 39.2* 20.1 26.9 43.8*
  2 y 23.6 33.2 44.2* 25.4 26.8 39.7* 20.9 26.3 43.5*
 Nitroglycerin, n%
  1 y 14.0 19.7 23.1* 15.1 17.4 20.6* 13.2 23.8 22.4*
  2 y 14.3 18.8 24.0* 15.4 16.9 20.9* 13.3 20.6 22.8*
ACE indicates angiotensin-converting enzyme; BMS, bare-metal stent; DES, drug-eluting stent; GPIIb/IIIa, glycoprotein IIb/IIIa inhibitors; PCI, percutaneous coronary 
intervention; TIMI, thrombolysis in myocardial infarction.
Data are presented as mean values with 95% CIs or as a percentage.
*P<0.05.
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have examined the role of employment status in relation to 
outcomes after STEMI.
Several studies of MI have reported that high-SES 
patients are more likely to receive guideline-recommended 
medications at discharge than are low-SES patients.5,6 
Other studies have observed that low-income patients 
were less likely to receive secondary medical prevention 
after 3 months24 and that discontinuation of evidence-based 
medication was associated with not graduating from high 
school.25 The latter study also reported that medication 
therapy discontinuation was associated with higher mortal-
ity. To our knowledge, none of the studies regarding SES-
related differences in clinical outcomes after STEMI has 
included information about secondary medical prevention. 
Therefore, it is unclear whether the reported SES-related 
differences in clinical outcome could be mediated by differ-
ences in the secondary medical prevention used during fol-
low-up. We observed no substantial SES-related differences 
in the use of guideline-recommended medications during 
the PPCI procedure or after 1 or 2 years. Thus, in the setting 
of a universal, tax-financed, healthcare system, the poor 
outcomes in low-SES patients seemed not to be explained 
by differences in acute treatment or long-term secondary 
medical prevention.
The fact that the poor outcome related to low SES was pri-
marily explained by differences in baseline characteristics, 
including higher comorbidity, highlights the need for primary 
prevention strategies. These strategies should be aimed at low-
SES groups.
Study Strengths and Limitations
The main strengths of this study are the large number of 
patients, the long follow-up period, the prospective, popu-
lation-based design, and the unambiguous individual-level 
 linkage between public data sources. The latter provided 
detailed information regarding patient characteristics, SES, 
Table 2. Crude and Adjusted Hazard Ratios of Clinical Endpoints at Maximum Follow-up According 
to Socioeconomic Status
Unadjusted HR 
(95% CI)
Adjusted 1* HR 
(95% CI)
Adjusted 2† HR 
(95% CI)
Adjusted 3‡ HR 
(95% CI)
MACE at maximum follow-up
Income
 High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Medium 1.46 (1.27–1.68) 1.17 (0.99–1.37) 1.16 (0.98–1.37) 1.15 (0.97–1.36)
 Low 1.68 (1.47–1.92) 1.12 (0.93–1.33) 1.09 (0.89–1.32) 1.06 (0.87–1.29)
Education
 Long 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Medium 1.01 (0.85–1.21) 0.92 (0.77–1.11) 0.93 (0.76–1.13) 0.94 (0.77–1.15)
 Short 1.19 (0.99–1.40) 0.93 (0.78–1.13) 0.88 (0.72–1.07) 0.87 (0.71–1.07)
Employment status
 Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Unemployed 1.75 (1.46–2.10) 1.27 (1.03–1.56) 1.23 (0.98–1.54) 1.15 (0.91–1.44)
 Pensioner 1.78 (1.58–2.01) 1.14 (0.95–1.36) 1.13 (0.93–1.37) 1.12 (0.93–1.36)
Cardiac mortality at maximum follow-up
Income
 High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Medium 2.30 (1.80–2.95) 1.22 (0.93–1.61) 1.07 (0.78–1.46) 1.05 (0.77–1.44)
 Low 3.92 (3.11–4.94) 1.30 (0.97–1.73) 1.23 (0.89–1.71) 1.22 (0.88–1.69)
Education
 Long 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Medium 0.96 (0.71–1.30) 0.83 (0.61–1.14) 0.82 (0.57–1.16) 0.82 (0.57–1.16)
 Short 1.66 (1.25–2.20) 0.93 (0.69–1.25) 0.75 (0.53–1.07) 0.74 (0.52–1.04)
Employment status
 Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Unemployed 4.09 (2.95–5.69) 1.70 (1.17–2.46) 1.31 (0.85–2.01) 1.18 (0.77–1.82)
 Pensioner 5.37 (4.18–6.89) 1.45 (1.04–2.01) 1.31 (0.90–1.91) 1.33 (0.91–1.93)
HR indicates hazard ratio; MACE, major adverse cardiac events (cardiac death, recurrent myocardial infarction and target 
vessel revascularization).
*Adjusted for patient characteristics and mutual adjustment for socioeconomic factors (see online-only Data Supplement 
Table I).
†Adjusted as in * and also for admission findings and procedure-related data (see online-only Data Supplement Table I).
‡Adjusted as in † and also for medical treatment during follow-up (see online-only Data Supplement Table I).
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treatment and use of medications, and allowed complete 
 follow-up, minimizing the risk of selection bias.
Thrombolysis is still widely used in most countries. The 
mechanisms that determine whether to use thrombolysis or 
PPCI are unclear. If these mechanisms differ among groups 
with different SESs, as some studies indicate,2,4,5 bias may 
result. The present study was conducted in Denmark, where 
STEMI patients are almost exclusively treated with PPCI. This 
clinical situation optimizes external validity and minimizes the 
risk of bias in this study because the Western Denmark Heart 
Registry contains data regarding all procedures without any 
inclusion or exclusion criteria. However, selection bias might 
be present if the risk of sudden cardiac death before hospital 
admission is associated with SES. Previous studies indicate 
that sudden cardiac death is associated with low SES.26 If this 
is the case, the SES-associated differences in outcomes that 
we report may be a conservative estimate of the true difference 
in outcomes.
The limitations of this study include the use of hospital dis-
charge diagnoses, which may not always be accurate. However, 
the validity of the majority of the diagnoses included in this 
study is high.27 Furthermore, any misclassification is unlikely to 
depend on SES. Furthermore, although we controlled for a wide 
range of factors that may affect clinical outcome, we cannot, 
due to the observational study design, exclude the possibility 
that confounding factors still influenced the results, including 
factors for which information was unavailable (eg, lifestyle 
habits and patient compliance). Race is often closely inter-
twined with SES5,6,20 and thus might bias the results because 
race data were unavailable. However, our results are not likely 
to be substantially biased by race because the population of 
Denmark is primarily white. Furthermore, although the study 
size was considerable, the statistical precision of the analyses 
illustrates that we were not able to completely rule out impor-
tant effects associated with differences in treatment as well.
Our results might not apply to countries without tax-
financed health care where SES-related differences in care 
may also contribute to the SES-related differences in clinical 
outcome. Our findings may, therefore, be a conservative esti-
mate of the SES-related differences in clinical outcome that 
could be found in such countries.
Conclusions
Even in a universal, tax-financed, healthcare system, low-
SES STEMI patients treated with PPCI face a worse prog-
nosis than high-SES patients. The poor outcome seems to be 
primarily explained by differences in baseline patient char-
acteristics, rather than differences in acute treatment or long-
term secondary medical prophylaxis. Employment status and 
income, but not education level, were associated with clinical 
outcomes.
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SUPPLEMENTAL MATERIAL 
Table I. Patient characteristics, admission findings and procedure related data, and medical treatment during follow-up according to socioeconomic status. 
Income Education 
 
Employment status Variable 
High 
(n = 2508) 
Medium 
(n = 2439) 
Low 
(n=2438) 
Long 
(n = 1013 ) 
Medium  
(n = 2582 ) 
Short 
(n=3790) 
Employed 
(n = 2826) 
Unemployed 
(n = 436) 
Pensioner 
(n=4123) 
Patient characteristics 
Male sex 82.1% 72.3% 64.9%* 82.0% 82.0% 64.8%* 84.4% 73.6% 65.4%* 
Age 
 <65 
 65-80 
 >80 
 
82.1% 
14.8% 
3.1% 
 
54.8% 
36.0% 
9.2% 
 
20.6%* 
55.1%* 
24.3%* 
 
65.5% 
30.0% 
4.5% 
 
66.5% 
29.2% 
4.4% 
 
40.1%* 
40.5%* 
19.4%* 
 
93.3% 
6.4% 
0.3% 
 
94.3% 
5.5% 
0.2% 
 
20.7%* 
57.9% 
21.5% 
Comorbidity 
 Low 
 Medium 
 High  
 
75.8% 
21.3% 
2.9% 
 
65.1% 
27.6% 
7.3% 
 
57.0%* 
32.2%* 
10.8%* 
 
75.2% 
21.5% 
3.3% 
 
68.6% 
25.2% 
6.3% 
 
61.9%* 
29.7%* 
8.4%* 
 
79.9% 
18.0% 
2.1% 
 
71.1% 
25.9% 
3.0% 
 
56.1%* 
33.2%* 
10.7%* 
Hypertension 26.2% 30.8% 35.0%* 29.5% 28.5% 32.3%* 22.9% 24.8% 36.5%* 
Hypercholesterolemia 24.0% 26.0% 26.6% 25.0% 26.9% 24.7% 22.2% 24.7% 27.9%* 
Diabetes 7.5% 9.5% 11.6%* 6.1% 8.5% 11.1%* 6.4% 9.7% 11.6%* 
Smoking status 
 Never 
 Previous  
 Active  
 
19.3% 
21.7% 
59.0% 
 
18.6% 
23.1% 
58.3% 
 
26.3%* 
28.3%* 
45.4%* 
 
25.4% 
27.0% 
47.6% 
 
17.3% 
24.6% 
58.1% 
 
22.9%* 
23.3% 
53.8%* 
 
16.3% 
18.2% 
65.5% 
 
13.3% 
14.2% 
72.5% 
 
25.8%* 
29.7%* 
44.5%* 
Previous myocardial 
infarction 
 
13.3% 
 
16.6% 
 
17.5%* 
 
13.2% 
 
15.5% 
 
16.6%* 
 
12.0% 
 
17.6% 
 
18.2%* 
Marital status 
 Divorced 
 Married 
 Unmarried  
 
18.9% 
70.6% 
10.5% 
 
29.6% 
58.8% 
11.6% 
 
30.7%* 
63.6%* 
5.7%* 
 
16.5% 
74.9% 
8.5% 
 
20.9% 
70.5% 
8.6% 
 
32.5%* 
57.4%* 
9.8% 
 
15.5% 
72.1% 
12.4% 
 
22.9% 
53.9% 
23.2% 
 
34.1%* 
60.2%* 
5.7%* 
Income 
 High 
 Medium 
 Low 
    
67.1% 
22.7% 
10.2% 
 
43.1% 
35.0% 
21.9% 
 
18.9%* 
34.5%* 
46.6%* 
 
68.4% 
27.0% 
4.6% 
 
24.8% 
44.7% 
30.5% 
 
11.3%* 
35.9%* 
52.8%* 
Employment status 
 Employed 
 Unemployed 
 Pensioner 
 
77.1% 
4.3% 
18.6% 
 
31.3% 
8.0% 
60.7% 
 
5.3%* 
5.5%* 
89.2%* 
 
57.1% 
7.0% 
35.9% 
 
50.9% 
6.7% 
42.4% 
 
24.6%* 
5.1%* 
70.3%* 
   
Education 
 Long 
 Medium 
 Short  
 
27.1% 
44.4% 
28.5% 
 
9.4% 
37.0% 
53.6% 
 
4.2%* 
23.2%* 
72.6%* 
    
20.5% 
46.5% 
33.0% 
 
16.3% 
39.5% 
44.3% 
 
8.8%* 
26.6%* 
64.6%* 
Admission findings & procedure related data 
Level of anemia 
 No anemia 
 Borderline  
 Mild  
 Severe  
 
77.0% 
17.3% 
5.4% 
0.3% 
 
70.5% 
19.2% 
9.6% 
0.7% 
 
65.5%* 
21.6%* 
11.7%* 
1.2%* 
 
74.9% 
18.3% 
6.3% 
0.5% 
 
74.2% 
18.0% 
7.0% 
0.8% 
 
67.8%* 
20.6% 
10.8%* 
0.7% 
 
78.3% 
16.5% 
5.0% 
0.2% 
 
81.2% 
15.1% 
3.4% 
0.3% 
 
65.0%* 
21.8%* 
12.1%* 
1.1%* 
Cholesterol, total 
(mmol/L) 
5.2 
(5.2–5.3) 
5.1 
(5.0–5.1) 
5.0 
(4.9-5.0)* 
5.1 
(5.0–5.2) 
5.1 
(5.1-5.2) 
5.1  
(5.0-5.1) 
5.3 
(5.2–5.3) 
5.2 
(5.1-5.4) 
5.0 
(4.9–5.0)* 
eGFR (mL/min/1.73          
m2) 
 >90  
 60-90 
 30-60 
 15-30 
 <15 
 
13.4% 
58.8% 
25.4% 
1.5% 
0.9% 
 
11.1% 
46.8% 
35.5% 
5.1% 
1.5% 
 
7.7%* 
35.0%* 
46.4%* 
8.5%* 
2.4%* 
 
10.8% 
52.3% 
33.5% 
1.9% 
1.5% 
 
12.7% 
53.1% 
29.8% 
3.4% 
1.0% 
 
9.4%* 
41.3%* 
40.2%* 
7.0%* 
2.1%* 
 
16.0% 
60.2% 
21.8% 
1.4% 
0.6% 
 
19.0% 
57.1% 
22.2% 
0.7% 
1.0% 
 
6.3%* 
36.9%* 
46.5%* 
7.9%* 
2.4%* 
Duration of 
symptoms (hours) 
3.3 
(3.3-3.4) 
3.4 
(3.3-3.5) 
3.7 
(3.6-3.8)* 
3.4 
(3.2–3.5) 
3.3  
(3.2-3.4) 
3.7 
(3.6-3.7)* 
3.3 
(3.2–3.4) 
3.3 
(3.1-3.5) 
3.6 
(3.6-3.7)* 
Killip class on 
admission 
 I 
 II 
 III 
 IV 
 
 
93.1% 
3.3% 
1.8% 
1.8% 
 
 
91.5% 
4.5% 
2.0% 
2.0% 
 
 
87.0%* 
6.9%* 
2.8%* 
3.3%* 
 
 
91.3% 
4.6% 
1.9% 
2.2% 
 
 
92.2% 
4.2% 
1.7% 
1.9% 
 
 
89.3%* 
5.4% 
2.6% 
2.7% 
 
 
93.8% 
3.0% 
1.6% 
1.6% 
 
 
91.9% 
4.4% 
2.1% 
1.6% 
 
 
88.2%* 
6.2%* 
2.6%* 
3.0%* 
Troponin-T (g/L) 2.8 
(2.6–3.0) 
3.1 
(2.9–3.2) 
3.1 
(2.9-3.4) 
3.1 
(2.8–3.5) 
2.8 
(2.6-3.0) 
3.1 
(2.9-3.3) 
3.0 
(2.8–3.2) 
2.9 
(2.4–3.5) 
3.0 
(2.8–3.2) 
CK-MB (g/L) 117 121 110 118  113 117 126 121 109 
(109–125) (113–129) (102-119) (107–131) (106-121) (111-124) (119–133) (103-142) (103–115) 
Sited culprit lesion 
 LM 
 LAD 
 LCx 
 RCA 
 
0.8% 
42.3% 
15.6% 
41.3% 
 
1.8% 
44.5% 
14.4% 
39.3% 
 
2.4%* 
42.2% 
13.8% 
41.5% 
 
1.1% 
43.2% 
13.6% 
42.1% 
 
1.7% 
43.7% 
15.6% 
39.0% 
 
1.8% 
42.4% 
14.3% 
41.5% 
 
0.9% 
43.1% 
15.3% 
40.7% 
 
1.2% 
46.9% 
16.5% 
35.4% 
 
2.3%* 
42.4% 
14.0% 
41.3% 
TIMI Grade flow 
before PCI 
 0 
 1 
 2 
 3 
 
 
58.9% 
5.6% 
13.6% 
21.9% 
 
 
55.8% 
6.9% 
14.3% 
23.1% 
 
 
57.1% 
7.4% 
13.1% 
22.3% 
 
 
57.4% 
6.1% 
13.9% 
22.6% 
 
 
57.6% 
6.2% 
13.8% 
22.4% 
 
 
57.1% 
7.0% 
13.5% 
22.4% 
 
 
59.2% 
5.4% 
14.3% 
21.1% 
 
 
57.2% 
6.2% 
13.2% 
23.4% 
 
 
56.0%* 
7.5%* 
13.3% 
23.2% 
TIMI Grade flow 
after PCI 
 0 
 1 
 2 
 
 
1.7% 
0.7% 
4.8% 
 
 
1.9% 
1.4% 
5.1% 
 
 
3.4%* 
1.4%* 
6.2% 
 
 
1.0% 
0.8% 
5.6% 
 
 
1.5% 
1.2% 
4.4% 
 
 
3.3%* 
1.4% 
5.9%* 
 
 
1.6% 
0.8% 
4.2% 
 
 
0.9% 
0.7% 
4.3% 
 
 
3.0%* 
1.5%* 
6.3%* 
 3 92.7% 91.5% 88.9%* 92.6% 92.9% 89.4%* 93.4% 94.1% 89.2%* 
Number of treated 
lesions 
 1 
 2 
 3 
 ≥4 
 
 
82.9% 
14.0% 
2.6% 
0.5% 
 
 
81.7% 
15.6% 
2.2% 
0.4% 
 
 
80.6% 
16.5% 
2.6% 
0.3% 
 
 
80.5% 
16.3% 
2.7% 
0.5% 
 
 
81.3% 
15.5% 
2.6% 
0.6% 
 
 
82.4% 
15.1% 
2.3% 
0.2% 
 
 
83.7% 
13.7% 
2.2% 
0.4% 
 
 
84.6% 
13.1% 
1.6% 
0.7% 
 
 
80.1%* 
16.8%* 
2.7% 
0.4% 
Stent implantation 94.4% 93.2% 91.1%* 94.4% 94.0% 91.8%* 95.4% 94.1% 91.0%* 
Stent type 
 BMS 
 DES 
 
50.0% 
50.0% 
 
53.3% 
46.7% 
 
59.0%* 
41.0%* 
 
48.6% 
51.4% 
 
50.3% 
49.7% 
 
58.0%* 
42.0%* 
 
48.6% 
51.4% 
 
48.7% 
51.3% 
 
58.4%* 
41.6%* 
Stent length (mm) 18.5 
(18.2–18.9) 
18.4 
(18.0–18.7) 
18.7 
(18.4-19.1) 
18.3 
(17.8–18.8) 
18.4 
(18.1-18.8) 
18.7 
(18.4-19.0) 
18.6 
(18.3–18.9) 
18.3 
(17.5-19.2) 
18.5 
(18.3–18.8) 
Procedure time (min) 19.6 
(19.1–20.1) 
20.1 
(19.5–20.7) 
20.4 
(19.6-21.1) 
20.1 
(19.3–20.9) 
20.1 
(19.5-20.7) 
19.9 
(19.5-20.4) 
19.3 
(18.8-19.8) 
19.9 
(18.6-21.3) 
20.5 
(20.0–20.9)* 
In-lab complication 2.3% 3.1% 3.5%* 2.5% 2.1% 3.7%* 2.2% 3.2% 3.4%* 
Successful procedure 97.0% 96.5% 93.8%* 97.5% 96.6% 94.8%* 97.6% 97.7% 94.4%* 
Red blood cell 
transfusion 
 
1.6% 
 
2.8% 
 
4.3%* 
 
2.5% 
 
2.1% 
 
3.5%* 
 
1.7% 
 
1.2% 
 
3.8%* 
Plasma transfusion 0.6% 1.0% 0.8% 1.1% 0.8% 0.7% 0.6% 0.2% 1.0% 
Platelet transfusion 0.5% 1.1% 0.6% 0.6% 0.7% 0.8% 0.5% 0.5% 0.9% 
Any transfusion 1.8% 3.2% 4.3%* 2.9% 2.3% 3.8%* 1.9% 1.4% 4.1%* 
Heparin during PCI 98.2% 98.2% 98.6% 98.0% 98.3% 98.4% 98.2% 97.7% 98.4% 
GPIIb/IIIa during PCI 73.9% 70.5% 64.5%* 74.2% 71.3% 67.3%* 75.2% 77.8% 65.0%* 
Aspirin during PCI 96.9% 96.9% 95.7% 95.9% 96.7% 96.6% 96.7% 96.8% 96.3% 
Clopidogrel during 
PCI 
 
84.4% 
 
82.8% 
 
83.2% 
 
84.5% 
 
84.4% 
 
82.6% 
 
84.3% 
 
81.5% 
 
83.2% 
Medical treatment during follow-up 
Aspirin 
 1 year 
 2 years 
 
91.8% 
89.4% 
 
91.0% 
88.8% 
 
90.7% 
89.0% 
 
89.4% 
87.3% 
 
91.1% 
88.7% 
 
91.7% 
89.8% 
 
92.5% 
89.6% 
 
87.7% 
84.4% 
 
90.5% 
89.2%% 
Clopidogrel 
 1 year 
 2 years 
 
67.1% 
8.7% 
 
66.4% 
10.3% 
 
65.9% 
9.8% 
 
67.4% 
10.5% 
 
67.5% 
10.1% 
 
65.5% 
8.9% 
 
66.6% 
8.1% 
 
63.5% 
12.6% 
 
66.8% 
10.3%* 
β-blocker 
 1 year 
 2 years 
 
82.1% 
76.6% 
 
82.2% 
78.7% 
 
79.9% 
76.6% 
 
79.5% 
74.7% 
 
83.5% 
78.4% 
 
80.5%* 
77.3%* 
 
82.7% 
77.4% 
 
77.4% 
71.5% 
 
81.0%* 
78.0%* 
Statin  
 1 year 
 2 years 
 
91.9% 
89.6% 
 
87.2% 
85.7% 
 
85.1%* 
83.8%* 
 
90.4% 
87.6% 
 
89.9% 
88.0% 
 
86.4%* 
85.2%* 
 
91.1% 
88.8% 
 
86.1% 
82.5% 
 
86.2%* 
85.3%* 
ACE-inhibitor  
 1 year 
 2 years 
 
54.6% 
52.7% 
 
55.7% 
54.0% 
 
58.1% 
57.9%* 
 
53.8% 
54.4% 
 
56.9% 
54.7% 
 
56.0% 
54.8% 
 
54.5% 
52.1% 
 
53.9% 
51.2% 
 
57.5%* 
57.2%* 
Diuretics 
 1 year 
 2 years 
 
22.3% 
23.6% 
 
34.4% 
33.2% 
 
43.9%* 
44.2%* 
 
25.5% 
25.4% 
 
27.2% 
26.8% 
 
39.2%* 
39.7%* 
 
20.1% 
20.9% 
 
26.9% 
26.3% 
 
43.8%* 
43.5%* 
Nitroglycerin 
 1 year 
 2 years 
 
14.0% 
14.3% 
 
19.7% 
18.8% 
 
23.1%* 
24.0%* 
 
15.1% 
15.4% 
 
17.4% 
16.9% 
 
20.6%* 
20.9%* 
 
13.2% 
13.3% 
 
23.8% 
20.6 
 
22.4%* 
22.8%* 
Data are presented as mean values with 95% confidence intervals, or as a percentage. ACE indicates angiotensin converting enzyme; BMS, bare 
metal stent; CK-MB, creatin kinase-myocardial band; DES, drug-eluting stent; eGFR, estimated glomerular filtration rate; GPIIb/IIIa, glycoprotein 
IIb/IIIa inhibitors; PCI, percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction. 
*p < 0.05  
 
 
 
 
 
 
 
 
 
 
 
Table II. Crude and adjusted hazard ratios of clinical endpoints at 30 days, 1 year, and maximum 
follow-up, according to socioeconomic status. 
 Unadjusted  
HR (95% CI) 
Adjusted 1* 
HR (95% CI) 
Adjusted 2† 
HR (95% CI) 
Adjusted 3‡ 
HR (95% CI) 
30-day MACE  
Income     
    High  1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.52 (1.21-1.92) 1.07 (0.82-1.40) 1.01 (0.75-1.36) 0.99 (0.73-1.33) 
    Low 2.26 (1.82-2.81) 1.14 (0.86-1.51) 1.09 (0.79-1.51) 1.08 (0.78-1.49) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)    1.00 (reference) 
    Medium 0.88 (0.66-1.18) 0.82 (0.61-1.11) 0.80 (0.58-1.12) 0.78 (0.56-1.09) 
    Short 1.21 (0.92-1.58) 0.83 (0.62-1.12) 0.70 (0.50-0.98) 0.67 (0.48-0.94) 
Employment status     
    Employed  1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 2.16 (1.58-2.97) 1.23 (0.86-1.77) 1.08 (0.71-1.62) 1.01 (0.67-1.53) 
    Pensioner 2.61 (2.11-3.22) 1.05 (0.77-1.42) 0.90 (0.63-1.27) 0.89 (0.63-1.26) 
1-year MACE  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.47 (1.24-1.74) 1.15 (0.95-1.39) 1.14 (0.92-1.40) 1.12 (0.91-1.38) 
    Low 1.79 (1.52-2.10) 1.08 (0.88-1.34) 1.05 (0.83-1.33) 1.03 (0.82-1.30) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 0.86 (0.70-1.07) 0.81 (0.65-1.00) 0.82 (0.65-1.04) 0.83 (0.66-1.05) 
    Short 1.15 (0.94-1.41) 0.90 (0.72-1.11) 0.84 (0.66-1.06) 0.83 (0.66-1.06) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.87 (1.49-2.35) 1.28 (0.99-1.65) 1.21 (0.91-1.60) 1.11 (0.84-1.47) 
    Pensioner 1.94 (1.67-2.25) 1.05 (0.84-1.30) 1.00 (0.79-1.27) 0.99 (0.78-1.26) 
30-day cardiac mortality  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 2.16 (1.59-2.92) 1.21 (0.86-1.70) 1.09 (0.73-1.62) 1.10 (0.74-1.63) 
    Low 3.52 (2.65-4.67) 1.24 (0.87-1.76) 1.20 (0.79-1.82) 1.22 (0.81-1.84) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)    1.00 (reference) 
    Medium 0.85 (0.59-1.24) 0.77 (0.52-1.13) 0.77 (0.50-1.21) 0.72 (0.46-1.15) 
    Short 1.49 (1.05-2.04) 0.89 (0.62-1.29) 0.72 (0.46-1.11) 0.66 (0.43-1.04) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 3.40 (2.24-5.16) 1.48 (0.93-2.38) 1.06 (0.61-1.85) 1.00 (0.58-1.74) 
    Pensioner 4.80 (3.55-6.49) 1.28 (0.85-1.92) 1.03 (0.64-1.66) 1.02 (0.63-1.65) 
1-year cardiac mortality  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 2.36 (1.79-3.13) 1.27 (0.93-1.73) 1.12 (0.78-1.61) 1.10 (0.76-1.58) 
    Low 3.90 (2.99-5.07) 1.28 (0.93-1.78) 1.25 (0.86-1.83) 1.24 (0.86-1.81) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 0.92 (0.65-1.30) 0.81 (0.57-1.15) 0.81 (0.54-1.22) 0.78 (0.52-1.18) 
    Short 1.69 (1.23-2.32) 0.95 (0.68-1.34) 0.69 (0.41-1.14) 0.74 (0.49-1.10) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 3.59 (2.44-5.28) 1.50 (0.97-2.31) 1.08 (0.65-1.79) 0.95 (0.57-1.58) 
    Pensioner 5.34 (4.03-7.07) 1.35 (0.93-1.97) 1.18 (0.76-1.81) 1.18 (0.77-1.82) 
1-year recurrent MI  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.43 (0.93-2.20) 1.38 (0.84-2.42) 1.39 (0.82-2.33) 1.40 (0.83-2.35) 
    Low 1.53 (0.99-2.35) 1.37 (0.77-2.42) 1.47 (0.80-2.71) 1.44 (0.78-2.65) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 0.85 (0.49-1.48) 0.76 (0.43-1.34) 0.82 (0.45-1.50) 0.86 (0.47-1.57) 
    Short 1.19 (0.71-2.00) 0.97 (0.55-1.70) 1.01 (0.40-2.57) 1.03 (0.57-1.88) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.53 (0.87-2.71) 1.20 (0.63-2.27) 0.96 (0.47-1.96) 0.84 (0.41-1.73) 
    Pensioner 1.30 (0.90-1.90) 1.02 (0.59-1.75) 1.01 (0.57-1.79) 0.98 (0.55-1.74) 
Recurrent MI at maximum follow-up  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.45 (1.09-1.92) 1.28 (0.93-1.71) 1.33 (0.95-1.88) 1.31 (0.93-1.85) 
    Low 1.32 (0.98-1.77) 1.12 (0.77-1.65) 1.19 (0.79-1.79) 1.15 (0.76-1.72) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 1.26 (0.85-1.88) 1.12 (0.74-1.67) 1.07 (0.70-1.63) 1.08 (0.71-1.65) 
    Short 1.38 (0.94-2.03) 1.18 (0.78-1.78) 1.16 (0.76-1.79) 1.16 (0.75-1.78) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.41 (0.96-2.07) 1.24 (0.81-1.90) 1.19 (0.75-1.88) 1.10 (0.69-1.75) 
    Pensioner 1.36 (1.06-1.75) 1.28 (0.89-1.84) 1.28 (0.87-1.88) 1.27 (0.87-1.87) 
30-day TVR  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 0.98 (0.62-1.32) 0.91 (0.59-1.40) 0.92 (0.58-1.47) 0.88 (0.55-1.39) 
    Low 0.91 (0.62-1.33) 0.92 (0.55-1.52) 0.84 (0.48-1.45) 0.81 (0.47-1.40) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)    1.00 (reference) 
    Medium 0.96 (0.60-1.53) 0.99 (0.61-1.59) 0.93 (0.57-1.54) 0.92 (0.56-1.52) 
    Short 0.78 (0.49-1.24) 0.81 (0.49-1.34) 0.75 (0.44-1.27) 0.76 (0.44-1.29) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.28 (0.77-2.15) 1.26 (0.70-2.25) 1.36 (0.72-2.58) 1.37 (0.72-2.61) 
    Pensioner 0.95 (0.68-1.33) 0.97 (0.59-1.61) 0.90 (0.52-1.54) 0.91 (0.53-1.56) 
1-year TVR   
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.09 (0.87-1.37) 1.09 (0.83-1.42) 1.15 (0.87-1.52) 1.15 (0.87-1.51) 
    Low 0.84 (0.65-1.08) 0.85 (0.61-1.17) 0.82 (0.58-1.15) 0.81 (0.57-1.14) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 0.85 (0.64-1.14) 0.85 (0.63-1.15) 0.87 (0.64-1.20) 0.90 (0.66-1.24) 
    Short 0.84 (0.63-1.11) 0.89 (0.66-1.21) 0.91 (0.66-1.26) 0.93 (0.67-1.29) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.43 (1.05-1.96) 1.51 (1.06-2.13) 1.55 (1.07-2.25) 1.45 (1.00-2.11) 
    Pensioner 0.93 (0.75-1.15) 1.07 (0.79-1.46) 1.04 (0.76-1.44) 1.01 (0.73-1.40) 
TVR at maximum follow-up  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 1.11 (0.93-1.34) 1.14 (0.92-1.41) 1.19 (0.95-1.48) 1.18 (0.94-1.47) 
    Low 0.77 (0.63-0.95) 0.87 (0.66-1.13) 0.87 (0.66-1.16) 0.85 (0.64-1.13) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 1.01 (0.79-1.29) 0.98 (0.76-1.25) 0.98 (0.75-1.27) 1.00 (0.77-1.29) 
    Short 0.87 (0.70-1.13) 0.94 (0.72-1.22) 0.94 (0.72-1.24) 0.95 (0.73-1.25) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 1.28 (1.00-1.65) 1.40 (1.05-1.85) 1.42 (1.05-1.91) 1.34 (1.00-1.81) 
    Pensioner 0.85 (0.71-1.01) 1.14 (0.89-1.46) 1.10 (0.85-1.43) 1.08 (0.83-1.40) 
30-day all-cause mortality  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 2.05 (1.56-2.70) 1.13 (0.83-1.54) 1.02 (0.71-1.46) 1.00 (0.69-1.44) 
    Low 3.27 (2.53-4.23) 1.16 (0.84-1.60) 1.14 (0.78-1.68) 1.15 (0.79-1.68) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)    1.00 (reference) 
    Medium 0.90 (0.64-1.27) 0.82 (0.57-1.16) 0.80 (0.53-1.21) 0.74 (0.49-1.13) 
    Short 1.52 (1.11-2.08) 0.91 (0.65-1.27) 0.73 (0.49-1.09) 0.68 (0.45-1.02) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 3.39 (2.32-4.97) 1.71 (1.11-2.62) 1.23 (0.74-2.03) 1.13 (0.68-1.87) 
    Pensioner 4.66 (3.54-6.14) 1.53 (1.05-2.21) 1.28 (0.83-1.98) 1.27 (0.82-1.96) 
1-year all-cause mortality  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 2.27 (1.80-2.86) 1.17 (0.90-1.52) 1.06 (0.78-1.42) 0.99 (0.74-1.34) 
    Low 3.77 (3.04-4.68) 1.20 (0.92-1.57) 1.21 (0.89-1.65) 1.15 (0.85-1.57) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 0.99 (0.75-1.32) 0.86 (0.64-1.15) 0.85 (0.61-1.18) 0.84 (0.60-1.17) 
    Short 1.67 (1.28-2.17) 0.93 (0.70-1.23) 0.79 (0.57-1.10) 0.79 (0.57-1.09) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 3.43 (2.47-4.76) 1.54 (1.07-2.22) 1.13 (0.73-1.73) 0.94 (0.61-1.45) 
    Pensioner 5.48 (4.34-6.93) 1.53 (1.12-2.09) 1.36 (0.95-1.94) 1.39 (0.98-1.98) 
All-cause mortality at maximum follow-up  
Income     
    High 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Medium 2.26 (1.93-2.63) 1.18 (1.00-1.41) 1.13 (0.93-1.37) 1.08 (0.89-1.31) 
    Low 3.91 (3.39-4.51) 1.28 (1.07-1.54) 1.31 (1.07-1.59) 1.27 (1.04-1.54) 
Education     
    Long 1.00 (reference) 1.00 (reference) 1.00 (reference)  1.00 (reference) 
    Medium 1.08 (0.89-1.31) 0.92 (0.75-1.12) 0.87 (0.70-1.08) 0.89 (0.72-1.11) 
    Short 1.67 (1.40-2.01) 0.90 (0.74-1.09) 0.88 (0.67-1.14) 0.81 (0.65-1.00) 
Employment status     
    Employed 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
    Unemployed 3.48 (2.83-4.27) 1.31 (1.03-1.67) 1.17 (0.90-1.53) 1.11 (0.84-1.45) 
    Pensioner 5.83 (4.99-6.82) 1.64 (1.33-2.02) 1.51 (1.21-1.89) 1.62 (1.29-2.03) 
CI indicates confidence interval; HR, hazard ratio; MI, myocardial infarction; TVR, target 
vessel revascularization. 
*Adjusted for patient characteristics and mutual adjustment for socioeconomic factors (see Data 
Supplement Table I) 
† Adjusted as in * and also for admission findings and procedure-related data (see Data 
Supplement Table I) 
‡ Adjusted as in † and also for medical treatment during follow-up (see Data Supplement Table 
I) 
